Lower levels of circulating IL-6 among persons with T2D has been observed compared to controls, suggesting IL-6 may play an anti-inflammatory role, and that persons with T2D have a poorer inflammatory response to tissue damage and infection [21]. This evidence concerns the gene IL6 and infection.